CJEM Subject Index - Index des sujets du JCMU

CAEP Administration

CJEM 2006;8(6):442

Index to Volume 8, 2006

A

acuity
317
acute coronary syndromes
27
acute ischemic stroke
54
acute myocardial infarction
27
adrenal insufficiency
349
advance care paramedics
401
advanced life support interventions
6
adverse drug effects
289
all-terrain vehicles
158, 277
amphotericin B
365
analgesia
85, 94
anticonvulsants
361
antidote
409
appendicitis
425
atlanto-occipital dislocation
50

B

basic life support interventions
6
bier block
247
brain natriuretic peptide
27

C

calculus
285
Canadian Emergency Department Triage and Acuity Scale
317
capnometry
94
cardiac arrest
13, 109, 329
cardiopulmonary resuscitation
13
cardiotoxicity
361
CEDIS
417
cervical rib
370
charcoal
358
chest pain
164
chest trauma
347
children
6, 158, 275, 425
children, injury pattern
277
composite hockey stick
347
computed tomography
425
CTAS
317

D

databases
417
demographics
269, 275
dexamethasone
393
diagnostic and treatment facility
247
diagnostic tests
251
disease prevention
100
dislocation
355

E

ED information systems
417
EDIS
417
emergency department, community
94
emergency department, rural
94
emergency cardiovascular care, resuscitation
37
emergency medical services
6
etomidate
347
eye
123

F–G

family physicians
94
felbamate
361
fentanyl
80
forearm injuries
247
gastrointestinal decontamination
358
general practitioners
94
glucose
339
guidelines
37

H

headache, benign
393
health promotion
100
headache, benign
393
heart failure
251
hockey stick, composite
347
hypothermia
109
hypothermia, induced
329

I

ice hockey
347
injury pattern
158
insulin
339
interfacility transfer, capacity
262
intravenous epinephrine
289
intravenous regional anesthesia
247
intravenous tPA
54
intubation
80, 347
intubation, rapid sequence
351
ischemia modified albumin
27
ischemic upper limb
370
IV–IA thrombolytic approach
54

K–L

ketamine
85
laboratory biomarkers
27
lamotrigine
361
lidocaine
80

M

medical records
417
midazolam
85
migraine
393
mortality
339
myocardial infarction
339, 401
myocardial ischemia
27

N

NT-proBNP
251
Naegleria fowleri
365
natriuretic peptides
251
neurologic injury, diagnosis of AOD
50
neuroprotection
80
neuron-specific enolase
13
nitroglycerin
164

O–P

orbital pseudotumour
123
outpatient management
247
overdose
409
patient expectations
148
pediatrics
275
pediatric emergency care
269
penetrating injury
347
perinephric
285
poisoning
409
predictive value of tests, outcome
13
priapism
119
primary amebic meningoencephalitis
365
primary care
247
procedural sedation
85, 94
propofol
85

Q–R

QRS prolongation
361
rapid sequence intubation
351
receiver operating characteristic curve, diagnosis
19
respiratory illness
323
RSI
351

S

safety effectiveness
94
SARS
323
satisfaction survey
148
severe acute respiratory syndrome
323
sensitivity
19
sepsis
339
sickle cell disease
119
sigmoid perforation
358
specificity
19
spinal trauma
50
socioeconomic status
269
sternoclavicular
355
stroke
339
subcutaneous abcess
285

T

therapeutic hypothermia
109
thoracic outlet syndrome
370
toxicology
409
transfusion
119
tricyclic antidepressant
361
trophozoite
365

U–V

ultrasonography
425
variant angina
289
visual change
123